openPR Logo
Press release

Cystinosis Treatment Market - Global Industry Insights, Trends, 2026

07-06-2018 11:56 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Cystinosis Treatment Market - Global Industry Insights,

Cystinosis is a condition characterized by accumulation of the cystine (amino acid) within cells. High amount of cystine damages cells and often forms crystals that can damage tissues and organs. The eyes and kidneys are mainly susceptible to damage; however, the pancreas, muscles, testes, and thyroid can also be affected. Cystinosis is categorized into three different types; nephropathic, non-nephropathic or ocular, and intermediate cystinosis. Nephropathic (infantile) cystinosis is the most severe and common form of cystinosis. Renal Fanconi syndrome and growth failure are usually the first noticeable symptoms of this disorder. Intermediate cystinosis is characterized by symptoms similar to that of nephropathic cystinosis. However, these symptoms are not prominent till age of 8-20 years. Non-nephropathic cystinosis generally affects adults during middle age with eye disorder. Kidney disease does not occur in these individuals. Individuals with non-nephropathic cystinosis develop photophobia due to cystine crystal accumulation in the eyes.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1660

All three types of cystinosis occur due to mutations in the CTNS gene. Mutations in CTNS gene cause deficiency of a transporter protein called cystinosin. Cystinosin normally moves cystine out of the lysosomes, which are compartments in the cell that recycle and digest materials. Defects in cystinosin, allows accumulation of cystine and forms crystals in the lysosomes and its buildup damages cells in the eyes and kidneys. According to National Institutes of Health (NIH), cystinosis affects around 1 in 100,000 to 200,000 infants globally. Cystinosis is the most common cause of renal Fanconi syndrome in children and accounts for nearly 5% of all childhood cases of kidney failure. Fanconi syndrome, a rare disorder of kidney tubule function results in excess amounts of potassium, uric acid, glucose, phosphates, bicarbonate, and certain amino acids excreted in the urine. Cysteine depleting therapy can significantly reduce cysteine levels inside the cells. It improves growth and decreases kidney damage in children. Symptomatic therapy treats renal Fanconi syndrome with a high intake of electrolytes and fluids to prevent extreme body dehydration. Sodium bicarbonate, potassium, sodium citrate, and magnesium can help to keep standard electrolyte stability. Acetyl cholinesterase (ACE) inhibitors are also used sometimes to limit the growth of the renal disease.

Cystinosis Treatment Market Dynamics

Various government grants to support the diagnosis and treatment of cystinosis is boosting growth of the market. For instance, in 2013, the Cystinosis Research Foundation awarded six grants worth US $1.29 million to Cystinosis researchers for developing better treatments and a cure for the disease. Organizations such as Cystinosis Research Network are responsible to spread awareness regarding disease by celebrating Cystinosis Awareness Day on May 7, every year. Furthermore, product approval by the Food and Drug Administration (FDA) is expected to boost growth of the cystinosis treatment market over the forecast period. In 2013, the FDA approved the delayed-release formulation of cysteamine bitartrate (DR-C) for patients aged 6 years and above, and the label was expanded in 2015 to include children age two years. Cysteamine is a cystine-depleting agents that reduces cystine levels in cells. It has proven to be effective in preventing or delaying renal failure and improving growth of children with Cystinosis. In 2013, FDA approved Cystaran (cysteamine ophthalmic solution) for the treatment of corneal cystine crystal accumulation. Treatment with Cystaran should be initiated as soon as cystine crystals are found within the corneas. Lack of focus on R&D due to low prevalence rate and limited treatment options can negatively impact cystinosis treatment.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/cystinosis-treatment-market-1660

Cystinosis treatment Market Regional Insights

Regional segmentation of Cystinosis treatment market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the expected to dominate the cystinosis treatment market. According to an article published by Cystinosis Research Network, an estimated 15 new nephropathic cystinosis cases are diagnosed in the U.S. annually. Moreover, the network also works on increasing awareness about disease among regional population. High prevalence rate of cystinosis in Europe is expected to drive growth of the cystinosis treatment market in the region. According to National Institutes of Health (NIH), cystinosis affects 1 in 26,000 persons in France.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://globalresearchtrends.blogspot.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystinosis Treatment Market - Global Industry Insights, Trends, 2026 here

News-ID: 1113474 • Views: 190

More Releases from Coherent Market Insights

N-Methyl Diethanolamine (MDEA) Market will generate new growth opportunities 202 …
Description New Research Study ❝N-Methyl Diethanolamine (MDEA) Market 2023 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook❝ has been added to Coherent Market insight The N-Methyl Diethanolamine (MDEA) Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development
A2 Milk Market Generated Opportunities, Future Scope 2023-2030 | Jersey Dairy, T …
Description New Research Study ❝A2 Milk Market 2023 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook❝ has been added to Coherent Market insight The A2 Milk Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development trend, analysis
Online Takeaway Food Market Is Booming Worldwide 2023-2030 | Just Eat plc., Grub …
Description New Research Study ❝Online Takeaway Food Market 2023 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook❝ has been added to Coherent Market insight The Online Takeaway Food Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development
Tissue Paper Market to See Booming Growth 2023-2030 | Kimberly-Clark Corporation …
Description New Research Study ❝Tissue Paper Market 2023 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook❝ has been added to Coherent Market insight The Tissue Paper Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development trend, analysis

All 5 Releases


More Releases for Cystinosis

Cystinosis Treatment Market Analysis, Competitive Assessment and Forecasts to 20 …
The latest Cystinosis Treatment Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Cystinosis Treatment Market. Cystinosis
Cystinosis Treatment Market 2021: Market Landscape, Market Sizing and Forecast u …
Cystinosis Treatment Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the Cystinosis Treatment market growth. Cystinosis or Nephropathic cystinosis is a kind
Nephropathic Cystinosis Treatment Market– Growth Opportunities & Technology De …
The report " Nephropathic Cystinosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025", has been prepared based on an in-depth market analysis with inputs from industry experts. The main objective of this report is to define, describe, and forecast the global “Nephropathic Cystinosis Treatment” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an
Cystinosis Disease Therapeutics Market: Regional Markets, Technology, Types, and …
Cystinosis is a rare disease and characterized by accumulation of cystine (a building block of proteins) inside cells. Increase in cystine damages cells and frequently forms crystals that can develop and cause issues in numerous organs and tissues. The kidneys and eyes are particularly defenseless to the damage. Muscles, thyroid, pancreas, and testicles could also be affected. Nephropathic cystinosis, intermediate cystinosis, and non-nephropathic cystinosis are the three types of cystinosis.
Nephropathic Cystinosis Treatment Market Estimated to Flourish by 2025
Nephropathic cystinosis is the leading lysosomal storage disorder caused due to malfunctioning lysosomal membrane transfusion, and it assists as a prototype for a small group of lysosomal transportation disorders. The disease leads to intracellular growth of cysteine in all tissues and organs. Nephropathic cystinosis is an uncommon autosomal recessive disorder with lysosomal storing of the amino acid cysteine due to a deficiency in the membrane transfusion protein, cystinosis. Meanwhile the
Latest Report on Nephropathic Cystinosis Treatment Market Size & Share, Growth, …
" Nephropathic Cystinosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" is the latest addition to MarketResearchReports.Biz industry research reports collection. ​The objective of this report is to define, describe, and forecast the market on the basis of type, application, medical condition, and region. It provides detailed information regarding the major factors influencing the growth of the market. This report also tracks and analyzes